Meet the expert at ASTRO 2018 with Dr Alexander Lin
Learn with our customers how they turn challenges into opportunities in their daily practice with proton therapy:
"Model-based clinical validation of proton...
Learn with our customers how they turn challenges into opportunities in their daily practice with proton therapy:
"Model-based clinical validation of proton...
This study by the researchers from Taiwan compared the incidence and severity of chronic rhinosinusitis (CRS) in NPC patients who were treated with IMPT (n=53)...
This study evaluated the health outcomes of 94 children with craniopharyngioma treated by protons. Body mass index, physical function and cardiopulmonary...
This study by the group from Prague, Czech Republic, reported early outcomes of 12 patients with glomus jugulare tumours (GJT) treated with IMPT to a median...
Proton particles do not deposit exit dose, which allows proton therapy to spare normal tissues distal to the tumor target. This is particularly useful for...
During ISOP 2022, Brandon Gunn presented the webinar "Proton Therapy for Head and Neck Cancer: Selection and management". Watch the webinar above.